Amylyx Pharmaceuticals, Inc.
AMLX
$32.40
-$1.48-4.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.37% | -11.74% | -7.85% | 90.23% | -11.39% |
| Total Receivables | 400.00% | -46.81% | -18.97% | -24.18% | -49.01% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.51% | -20.73% | -29.00% | -22.51% | -49.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.06% | -11.94% | -8.41% | 89.09% | -13.53% |
|
|
|||||
| Total Current Assets | -10.06% | -11.94% | -8.41% | 89.09% | -13.53% |
| Net Property, Plant & Equipment | -6.93% | -7.25% | -6.54% | -6.11% | 201.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.09% | 0.00% | 140.04% | -0.62% |
| Total Assets | -9.89% | -11.74% | -8.30% | 86.41% | -11.42% |
|
|
|||||
| Total Accounts Payable | 56.79% | 0.28% | -34.09% | 62.08% | -31.52% |
| Total Accrued Expenses | 29.49% | -37.01% | -8.02% | 11.49% | 44.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.73% | -8.26% | 28.34% | 47.52% | -36.97% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.47% | -29.63% | -12.03% | 20.38% | 19.47% |
|
|
|||||
| Total Current Liabilities | 32.47% | -29.63% | -12.03% | 20.38% | 19.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.12% | -4.73% | -5.17% | -6.48% | 1,519.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.24% | -25.36% | -10.93% | 15.06% | 46.34% |
|
|
|||||
| Common Stock & APIC | 0.91% | 0.89% | 0.64% | 23.28% | 0.87% |
| Retained Earnings | -5.48% | -5.49% | -4.59% | -5.03% | -6.45% |
| Treasury Stock & Other | -92.08% | -40.59% | -50.43% | 47.91% | -- |
| Total Common Equity | -12.44% | -10.52% | -8.05% | 97.76% | -16.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.44% | -10.52% | -8.05% | 97.76% | -16.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.44% | -10.52% | -8.05% | 97.76% | -16.65% |
|
|
|||||